Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-19,700
Closed -$13K 5603
2021
Q2
$13K Buy
19,700
+8,900
+82% +$29K ﹤0.01% 3657
2021
Q1
$3K Buy
+10,800
New +$30.5K ﹤0.01% 4626
2019
Q4
Sell
-14,900
Closed -$1K 3884
2019
Q3
$1K Buy
14,900
+10,500
+239% +$50.3K ﹤0.01% 3642
2019
Q2
$1K Buy
+4,400
New +$19.7K ﹤0.01% 3753
2019
Q1
Sell
-65,700
Closed -$1K 3929
2018
Q4
$1K Buy
65,700
+31,700
+93% +$135K ﹤0.01% 3535
2018
Q3
$5K Buy
+34,000
New +$162K ﹤0.01% 3002
2016
Q3
Sell
-11,300
Closed -$10K 6560
2016
Q2
$10K Buy
+11,300
New +$60.7K ﹤0.01% 4095

Other funds holding ABEV

Cutler Group's ABEV Position: Q4 2022 in Review

Cutler Group sold out of Ambev (ABEV) in Q4 2022, closing a stake of 500 shares — an estimated $1.46K sold.

Cutler Group first reported a position in ABEV in Q4 2015 and held it in 22 quarters. The position peaked at $131K in Q3 2016. 314 funds tracked by Wall St. Rank hold ABEV as of Q4 2022.

  • Cutler Group reported no remaining Ambev position as of Q4 2022 after selling out during the quarter.
  • Cutler Group sold 500 Ambev shares in Q4 2022, an estimated $1.46K.
  • Cutler Group first reported a position in Ambev in Q4 2015 and held it in 22 quarters.
  • Cutler Group's Ambev position peaked at $131K in Q3 2016.
  • 314 funds tracked by Wall St. Rank held Ambev as of Q4 2022.

Based on Cutler Group's 13F filing for Q4 2022, filed 7 Feb 2023.